BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4176638)

  • 21. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
    Földes J; Takó J; Bános C; Gesztesi E; Varga I
    Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
    [No Abstract]   [Full Text] [Related]  

  • 22. ["Long-acting thyroid stimulator" (LATS) and conventional thyroid antibodies. Comparative studies].
    Depisch D; Höfer R; Schatz H
    Wien Z Inn Med; 1968; 49(11):418-22. PubMed ID: 5737591
    [No Abstract]   [Full Text] [Related]  

  • 23. Antibody binding of thyroxine in the primate subjected to hetero- and isoimmunization against components of the thyroid gland.
    Premachandra BN
    Endocrinology; 1970 Mar; 86(3):703-6. PubMed ID: 4189853
    [No Abstract]   [Full Text] [Related]  

  • 24. The production of thyroid autoantibodies in mice.
    Twarog FJ; Rose NR
    J Immunol; 1968 Aug; 101(2):242-50. PubMed ID: 5668024
    [No Abstract]   [Full Text] [Related]  

  • 25. Thyroidal effects of injections of Graves' disease thyroid microsomes in rhesus monkeys.
    Furth ED; Dentinger M
    Endocrinology; 1971 Jul; 89(1):310-5. PubMed ID: 4103749
    [No Abstract]   [Full Text] [Related]  

  • 26. Induction of thyroiditis in the rabbit by intravenous infection of papain-treated rabbit thyroglobulin.
    Anderson CL; Rose NR
    J Immunol; 1971 Nov; 107(5):1341-8. PubMed ID: 5000725
    [No Abstract]   [Full Text] [Related]  

  • 27. LATS protector, the human thyroid stimulator.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
    [No Abstract]   [Full Text] [Related]  

  • 28. Evidence to suggest that LATS protector stimulates the human thyroid gland.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1971 Jul; 33(1):47-51. PubMed ID: 5558041
    [No Abstract]   [Full Text] [Related]  

  • 29. Preparation and binding of antimicrosomal antibody-free LATS, and the effect of iodination on LATS biological activity.
    Mori T; Kriss JP
    J Clin Endocrinol Metab; 1971 Nov; 33(5):813-21. PubMed ID: 5166460
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on the thyroid gland component inhibiting LATS.
    Schleusener H; Murthy PV; McKenzie JM
    Metabolism; 1971 Mar; 20(3):299-308. PubMed ID: 4993770
    [No Abstract]   [Full Text] [Related]  

  • 31. Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick.
    Lepp A; Oliner L
    Endocrinology; 1967 Feb; 80(2):369-74. PubMed ID: 4163488
    [No Abstract]   [Full Text] [Related]  

  • 32. Radioimmunoassay for human antithyroglobulin antibodies. I. The relationship between tanned cell haemagglutination and a double antibody technique.
    Salabé GB; Fontana S; Andreoli M
    Hormones; 1972; 3(1):1-13. PubMed ID: 4120243
    [No Abstract]   [Full Text] [Related]  

  • 33. Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1967 Feb; 27(2):173-7. PubMed ID: 4163610
    [No Abstract]   [Full Text] [Related]  

  • 34. LATS inhibition by a soluble lipoprotein from human thyroid gland.
    Chopra IJ; Beall GN; Solomon DH
    J Clin Endocrinol Metab; 1971 Jun; 32(6):772-8. PubMed ID: 5577160
    [No Abstract]   [Full Text] [Related]  

  • 35. LATS and Graves' disease.
    Soloman DH; Chopra IJ
    Calif Med; 1970 Aug; 113(2):50-5. PubMed ID: 5538194
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunological mechanisms in thyrotoxicosis].
    Bradistilov S
    Vutr Boles; 1979; 18(2):9-16. PubMed ID: 380170
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of long-acting thyroid stimulator on thyrotropin stimulation of adenyl cyclase activity in thyroid plasma membranes.
    Yamashita K; Field JB
    J Clin Invest; 1972 Mar; 51(3):463-72. PubMed ID: 4110896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can LATS be detected by immunofluorescence?
    Beall GN; Solomon DH; Doniach D; Roitt IM
    J Clin Endocrinol Metab; 1969 Aug; 29(8):1114-6. PubMed ID: 4895860
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of immunization of baboons with human thyroid tissue.
    Beall GN; Daniel PM; Pratt OE; Solomon DH
    J Clin Endocrinol Metab; 1969 Nov; 29(11):1460-9. PubMed ID: 4981680
    [No Abstract]   [Full Text] [Related]  

  • 40. LATS production by lymphocyte culture in patients with Graves' disease.
    Miyai K; Fukuchi M; Kumahara Y; Abe H
    J Clin Endocrinol Metab; 1967 Jun; 27(6):855-60. PubMed ID: 4165125
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.